Search - tctmd.com

Displaying 921 - 940 of 1522

Sort: Relevancy | Date

Presentation TCT 2015

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore

October 14, 2015

Presentation TCT 2015

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

Presenter: Eric R. Bates, Spencer B. King III, Sanjay Kaul

October 13, 2015

$Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Unfractionated Heparin!$

Presentation TCT 2015

Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Unfractionated Heparin!

Presenter: John A. Bittl, Robert A. Harrington, Michael S. Lee

October 12, 2015

Presentation TCT 2015

Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Bivalirudin!

Presenter: John A. Bittl, Robert A. Harrington, George D. Dangas

October 12, 2015

Presentation TCT 2015

Is Prolonged Antithrombin Use After Primary PCI in STEMI Beneficial?

Presenter: John A. Bittl, Robert A. Harrington, Mahesh Madhavan

October 12, 2015

Presentation TCT 2015

Aortic Stenosis With Simple and Complex CAD: Thoughtful Commentary on the Case (ACTIVATION Trial)

Presenter: Robert O. Bonow, Allan Schwartz, Simon Redwood

October 12, 2015

Presentation TCT 2015

Aortic Stenosis With Simple and Complex CAD: Case Presentation

Presenter: Robert O. Bonow, Allan Schwartz, Jean-Michel Paradis

October 12, 2015

Presentation TCT 2015

Procedural Anticoagulants in Sweden: Results From the SCAAR Registry and Rationale for VALIDATE-SWEDEHEART

Presenter: John A. Bittl, Robert A. Harrington, David Erlinge

October 12, 2015

Presentation TCT 2015

Cangrelor + Bivalirudin: The Perfect Marriage or a Forced Union?

Presenter: John A. Bittl, Robert A. Harrington, Harvey D. White

October 12, 2015

Presentation TCT 2015

What, if Any, Is the Role for LMWH and GP IIb/IIIa Inhibitors in ACS or During PCI?

Presenter: John A. Bittl, Robert A. Harrington, Jorge F. Saucedo

October 12, 2015

Presentation TCT 2015

Bivalirudin Pearls: Necessity With Radial Access, Infusion Dose and Duration, Use in CKD, and More

Presenter: John A. Bittl, Robert A. Harrington, Philippe Gabriel Steg

October 12, 2015

Presentation TCT 2015

Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results

Presenter: John A. Bittl, Robert A. Harrington, Marco Valgimigli

October 12, 2015

Presentation TCT 2015

iFR and Pd/Pa to Guide PCI in Diffuse and Multivessel CAD: A Case-Based Review

Presenter: Habib Samady, Justin E. Davies

October 12, 2015

Presentation TCT 2015

PCI for Multivessel Disease in the CABG Candidate: Should We Follow the Guidelines? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Minh Vo

October 11, 2015

Presentation TCT 2015

PCI for Multivessel Disease With CTO: When and How? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Cheol Woong Yu

October 11, 2015

Presentation TCT 2015

A Practical Stenting Issue in Multivessel Disease: When and Where to Stop? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Kevin Bainey

October 11, 2015

Presentation TCT 2015

How to Apply Physiology-Guided PCI for MVD

Presenter: Thomas Engstroem, Manh-Hung Pham, Chang-Wook Nam

October 11, 2015

Presentation TCT 2015

One-Stage vs Delayed PCI for Nonculprit Lesion in Patients With AMI and Multivessel Disease

Presenter: Thomas Engstroem, Manh-Hung Pham, Henning Kelbæk

October 11, 2015

Presentation TCT 2015

Complete vs Incomplete Revascularization

Presenter: Thomas Engstroem, Manh-Hung Pham, David A. Wood

October 11, 2015

Presentation TCT 2015

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Presenter: Taehoon Ahn, Robert C. Welsh, Quang Ngoc Nguyen

October 11, 2015

Advertisement

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Unfractionated Heparin!

Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Bivalirudin!

Is Prolonged Antithrombin Use After Primary PCI in STEMI Beneficial?

Aortic Stenosis With Simple and Complex CAD: Thoughtful Commentary on the Case (ACTIVATION Trial)

Aortic Stenosis With Simple and Complex CAD: Case Presentation

Procedural Anticoagulants in Sweden: Results From the SCAAR Registry and Rationale for VALIDATE-SWEDEHEART

Cangrelor + Bivalirudin: The Perfect Marriage or a Forced Union?

What, if Any, Is the Role for LMWH and GP IIb/IIIa Inhibitors in ACS or During PCI?

Bivalirudin Pearls: Necessity With Radial Access, Infusion Dose and Duration, Use in CKD, and More

Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results

iFR and Pd/Pa to Guide PCI in Diffuse and Multivessel CAD: A Case-Based Review

PCI for Multivessel Disease in the CABG Candidate: Should We Follow the Guidelines? With Case Examples

PCI for Multivessel Disease With CTO: When and How? With Case Examples

A Practical Stenting Issue in Multivessel Disease: When and Where to Stop? With Case Examples

How to Apply Physiology-Guided PCI for MVD

One-Stage vs Delayed PCI for Nonculprit Lesion in Patients With AMI and Multivessel Disease

Complete vs Incomplete Revascularization

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content